Optina Diagnostics

Optina Diagnostics company information, Employees & Contact Information

Updated May 2026

Quick answer

Optina Diagnostics is a Medical Device company and founded in 2011. It has approximately 25 employees on record. Contact data was last refreshed in May 2026. Find Optina Diagnostics's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Optina Diagnostics is revolutionizing medical diagnostics with our Retinal Deep Phenotyping platform that brings clarity and accessibility to early-stage diagnosis of diseases of the eye, and so much more. Optina aims to improve the lives of older adults by making diagnosis and precision medicine a reality. We are addressing major challenges faced by healthcare systems that support aging populations. The Optina-4C hyperspectral camera for imaging the retina (back of the eye) is FDA-cleared and licensed by Health Canada. It brings a new dimension to medical imaging - the power of the spectral (color) dimension - and reveals unprecedented information about cellular and molecular changes. Optina's Retinal Deep Phenotyping platform combines data-rich images from the Optina-4C camera with Artificial intelligence-driven algorithms to deliver automated, accessible, and equitable diagnostic information about eye diseases like Age-related Macular Degeneration, as well as systemic diseases like Alzheimer's and cardiac stenosis. Optina has been granted Breakthrough Device Designation by the FDA for our Alzheimer's test which enables a dramatic improvement in the differential diagnosis of dementia.

Company Details

Employees
25
Founded
-
Address
8200 Décarie Blvd, Suite 220,canada
Phone
(514) 394-0797
Email
in****@****adx.com
Industry
Medical Device
HQ
Montréal, QC
Looking for a particular Optina Diagnostics employee's phone or email?

Optina Diagnostics Questions

News

Optina Diagnostics Closes an Oversubscribed Series-A Round of CA$24.8 million - PR Newswire

Optina Diagnostics Closes an Oversubscribed Series-A Round of CA$24.8 million PR Newswire

Optina announces a US$2.1M investment from the Diagnostics Accelerator at the Alzheimer's Drug Discovery Foundation (ADDF) - PR Newswire Canada

Optina announces a US$2.1M investment from the Diagnostics Accelerator at the Alzheimer's Drug Discovery Foundation (ADDF) PR Newswire Canada

Top Optina Diagnostics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant